Patents by Inventor Wieslaw Mieczyslaw Kazmierski

Wieslaw Mieczyslaw Kazmierski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20210186960
    Abstract: Provided are IDO1 inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: December 5, 2018
    Publication date: June 24, 2021
    Inventor: Wieslaw Mieczyslaw KAZMIERSKI
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20210139467
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: June 27, 2018
    Publication date: May 13, 2021
    Inventors: Martha Alicia DE LA ROSA, Wieslaw Mieczyslaw KAZMIERSKI
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20210078988
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: June 27, 2018
    Publication date: March 18, 2021
    Inventors: Ghotas EVINDAR, Wieslaw Mieczyslaw KAZMIERSKI, John Franklin MILLER, Vicente SAMANO, Lita SUWANDI, David TEMELKOFF, Yoshiaki WASHIO, Bing XIA
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10927078
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: February 23, 2021
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Martha Alicia De La Rosa, Wieslaw Mieczyslaw Kazmierski, Yoshiaki Washio
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10906924
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: February 2, 2021
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Martha Alicia De La Rosa, Hongfeng Deng, Ghotas Evindar, Wieslaw Mieczyslaw Kazmierski, John Franklin Miller, Vicente Samano, Yoshiaki Washio, Bing Xia
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10899754
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases such as chronic viral infection, chronic bacterial infections, cancer, sepsis or a neurological disorder.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: January 26, 2021
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Martha Alicia De La Rosa, Wieslaw Mieczyslaw Kazmierski, Vicente Samano
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10787442
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: September 29, 2020
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: John G. Catalano, Martha Alicia De La Rosa, Wieslaw Mieczyslaw Kazmierski, Vicente Samano
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20200239420
    Abstract: Provided are IDO1 inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: October 26, 2018
    Publication date: July 30, 2020
    Inventor: Wieslaw Mieczyslaw KAZMIERSKI
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20200165201
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: June 27, 2018
    Publication date: May 28, 2020
    Inventors: Martha Alicia DE LA ROSA, Wieslaw Mieczyslaw KAZMIERSKI, Yoshiaki WASHIO
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20200165280
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: June 27, 2018
    Publication date: May 28, 2020
    Inventors: Martha Alicia DE LA ROSA, Hongfeng DENG, Ghotas EVINDAR, Wieslaw Mieczyslaw KAZMIERSKI, John Franklin MILLER, Vicente SAMANO, Yoshiaki WASHIO, Bing XIA
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20200115374
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases such as chronic viral infection, chronic bacterial infections, cancer, sepsis or a neurological disorder.
    Type: Application
    Filed: December 15, 2017
    Publication date: April 16, 2020
    Inventors: Martha Alicia DE LA ROSA, Wieslaw Mieczyslaw KAZMIERSKI, Vicente SAMANO
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10538495
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: January 21, 2020
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Brian Alvin Johns, Wieslaw Mieczyslaw Kazmierski, Martha Alicia De La Rosa, Vicente Samano
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10472336
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: November 12, 2019
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Pek Yoke Chong, Martha Alicia De La Rosa, Hamilton D. Dickson, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Vincent Wing-Fai Tai
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20190322652
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: December 15, 2017
    Publication date: October 24, 2019
    Inventors: John G. CATALANO, Martha Alicia DE LA ROSA, Wieslaw Mieczyslaw KAZMIERSKI, Vicente SAMANO
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10358427
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: July 23, 2019
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Pek Yoke Chong, Martha Alicia De La Rosa, Hamilton D. Dickson, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Vincent Wing-Fai Tai
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20190119223
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: May 11, 2017
    Publication date: April 25, 2019
    Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Brian Alvin JOHNS, Wieslaw Mieczyslaw KAZMIERSKI, Martha Alicia DE LA ROSA, Vicente SAMANO
  • Inhibitors of indoleamine 2,3-dioxygenase
    Patent number: 10239894
    Abstract: Provided are compounds of formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: March 26, 2019
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Wieslaw Mieczyslaw Kazmierski, Martha Alicia De La Rosa, Vicente Samano
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20190040023
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Application
    Filed: September 22, 2016
    Publication date: February 7, 2019
    Inventors: Pek Yoke CHONG, Martha Alicia DE LA ROSA, Hamilton D DICKSON, Wieslaw Mieczyslaw KAZMIERSKI, Vicente SAMANO, Vincent Wing-Fai TAI
  • INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20180298035
    Abstract: Provided are compounds of formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of HIV; including the prevention of the progression of AIDS and general immunosuppression.
    Type: Application
    Filed: June 30, 2016
    Publication date: October 18, 2018
    Inventors: Wieslaw Mieczyslaw KAZMIERSKI, Martha Alicia DE LA ROSA, Vicente SAMANO
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20180290988
    Abstract: This invention is directed to photoluminescent compounds based on rhodamine dyes with green emission and uses thereof for photoluminescence based devices.
    Type: Application
    Filed: September 22, 2016
    Publication date: October 11, 2018
    Inventors: Pek Yoke CHONG, Martha Alicia DE LA ROSA, Hamilton D. DICKSON, Wieslaw Mieczyslaw KAZMIERSKI, Vicente SAMANO, Vincent Wing-Fai TAI